Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis

• Xiewei Huang,
• Yushuai Yu,
• Shiping Luo,
• Wenfen Fu,
• Jie Zhang,
• Chuangui Song

Affiliations

Xiewei Huang

Department of Breast Surgery, Fujian Medical University Union Hospital

Yushuai Yu

Department of Breast Surgery, Fujian Medical University Union Hospital

Shiping Luo

Department of Breast Surgery, Fujian Medical University Union Hospital

Wenfen Fu

Department of Breast Surgery, Fujian Medical University Union Hospital

Jie Zhang

Department of Breast Surgery, Fujian Medical University Union Hospital

Chuangui Song

Department of Breast Surgery, Fujian Medical University Union Hospital